Cargando…

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer

BACKGROUND: Tumor stroma plays an important role in the progression and metastasis of colon cancer. The glycoproteins versican and lumican are overexpressed in colon carcinomas and are associated with the formation of tumor stroma. The aim of the present study was to investigate the potential progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Wit, Meike, Belt, Eric J. Th., Delis-van Diemen, Pien M., Carvalho, Beatriz, Coupé, Veerle M. H., Stockmann, Hein B. A. C., Bril, Herman, Beliën, Jeroen A. M., Fijneman, Remond J. A., Meijer, Gerrit A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2012
Materias:	Translational Research and Biomarkers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857876/ https://www.ncbi.nlm.nih.gov/pubmed/22711178 http://dx.doi.org/10.1245/s10434-012-2441-0

Ejemplares similares

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017)

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
por: den Uil, Sjoerd H., et al.
Publicado: (2019)

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
por: Lenos, Kristiaan, et al.
Publicado: (2015)

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
por: Sillars-Hardebol, Anke H., et al.
Publicado: (2010)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
por: Goos, Jeroen A.C.M., et al.
Publicado: (2015)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Sluiter, N. R., et al.
Publicado: (2016)

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
por: Jodal, Henriette C., et al.
Publicado: (2023)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
por: van der Meijde, Elisabeth, et al.
Publicado: (2016)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
por: Vleugels, Jasper L.A., et al.
Publicado: (2019)

Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients
por: Maeda, N., et al.
Publicado: (2014)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
por: Komor, Malgorzata A., et al.
Publicado: (2019)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC)
por: Kakchekeeva, Tinatin, et al.
Publicado: (2016)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

tranSMART
por: Bierkens, Mariska, et al.
Publicado: (2015)

Peritoneal Tumorigenesis and Inflammation are Ameliorated by Humidified-Warm Carbon Dioxide Insufflation in the Mouse
por: Carpinteri, Sandra, et al.
Publicado: (2015)

Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)

Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Radioimmunotherapy Improves Survival of Rats with Microscopic Liver Metastases of Colorectal Origin
por: de Jong, Gabie M., et al.
Publicado: (2009)

High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett’s Esophagus and Adenocarcinoma
por: Fisher, Oliver M., et al.
Publicado: (2014)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
por: Chen, Lei, et al.
Publicado: (2010)

Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival
por: Kwakman, R, et al.
Publicado: (2015)

Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure
por: Boorsma, Eva M., et al.
Publicado: (2021)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
por: Ohuchida, Kenoki, et al.
Publicado: (2011)

Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer
por: Sakai, Hiroshi, et al.
Publicado: (2011)

Clinicopathological Significance of BMP7 Expression in Esophageal Squamous Cell Carcinoma
por: Megumi, Koichi, et al.
Publicado: (2011)

KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy
por: Siddiqui, Ahmad D., et al.
Publicado: (2009)

Alterations of Circulating Bone Marrow–Derived VEGFR-2(+) Progenitor Cells in Isolated Limb Perfusion With or Without rhTNF-α
por: Nowak, Kai, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9g49vihu0e0aiqi5hlbnkk4763